Niagen Bioscience NAGE
NASDAQ NAGE
$3.17 +0.06 (+1.93%)
As of: Sep 4, 2026 · 3:59 PM EDT

Niagen Bioscience (NAGE) Restructuring Costs (2014 - 2015)

Niagen Bioscience (NAGE) posted quarterly Restructuring Costs of $418000.0 for Q4 2015, up 7.73% year-over-year from $388000.0 in Q4 2014, and down 5.43% quarter-over-quarter from $442000.0 in Q3 2015.

Analysis

Niagen Bioscience (NAGE) Restructuring Costs (2014 - 2015) Analysis & Trends

Niagen Bioscience (NAGE) has reported Restructuring Costs for 2 consecutive years, with $418000.0 the latest figure, recorded in Q4 2015.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Niagen Bioscience 251.05 Mn 184.31 Mn 19.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Oct 3, 2015 418,000.00
Jul 4, 2015 442,000.00
Sep 27, 2014 388,000.00
Jun 28, 2014 1.02 Mn